139 related articles for article (PubMed ID: 28000339)
21. [Changes in the prevalence of statin use in Germany - findings from national health interview and examination surveys 1997-1999 and 2008-2011].
Knopf HC; Busch MA; Du Y; Truthmann J; Schienkiewitz A; Scheidt-Nave C
Z Evid Fortbild Qual Gesundhwes; 2017 May; 122():22-31. PubMed ID: 28511896
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of atherogenic dyslipidemia in primary care patients at moderate-very high risk of cardiovascular disease. Cardiovascular risk perception.
Plana N; Ibarretxe D; Cabré A; Ruiz E; Masana L
Clin Investig Arterioscler; 2014; 26(6):274-84. PubMed ID: 24931442
[TBL] [Abstract][Full Text] [Related]
23. Comparison of 3 risk estimators to guide initiation of statin therapy for primary prevention of cardiovascular disease.
Ofori S; Dodiyi-Manuel S; Akpa MR
J Clin Lipidol; 2017; 11(6):1441-1447. PubMed ID: 29050979
[TBL] [Abstract][Full Text] [Related]
24. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
25. [Dyslipemia in diabetics treated with statins. Results of the DYSIS study in Spian].
Millán J; Alegría E; Guijarro C; Lozano JV; Vitale GC; González-Timón B; González-Juanatey JR
Med Clin (Barc); 2013 Nov; 141(10):430-6. PubMed ID: 23246165
[TBL] [Abstract][Full Text] [Related]
26. Inverse correlation between serum irisin and cardiovascular risk factors among Chinese overweight/obese population.
Liu R; Zhang Q; Peng N; Xu S; Zhang M; Hu Y; Chen Z; Tang K; He X; Li Y; Shi L
BMC Cardiovasc Disord; 2021 Nov; 21(1):570. PubMed ID: 34847893
[TBL] [Abstract][Full Text] [Related]
27. Persistent lipid abnormalities in patients with hypertension and dyslipidemia treated with statins: results of the Portuguese hypertensive subpopulation of the Dyslipidemia International Study (DYSIS).
Silva PM; Cardoso SM; Ferreira AM
Clin Exp Hypertens; 2015; 37(2):116-21. PubMed ID: 24785978
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and treatment of diabetes mellitus and hypertension among older adults with intellectual disability in comparison with the general population.
Axmon A; Ahlström G; Höglund P
BMC Geriatr; 2017 Nov; 17(1):272. PubMed ID: 29169334
[TBL] [Abstract][Full Text] [Related]
29. Enzyme-inducing antiepileptic drugs and fractures in people with epilepsy: A systematic review.
Fraser LA; Burneo JG; Fraser JA
Epilepsy Res; 2015 Oct; 116():59-66. PubMed ID: 26354168
[TBL] [Abstract][Full Text] [Related]
30. The association between antiepileptic drug and HMG-CoA reductase inhibitor co-medication and cholesterol management in patients with epilepsy.
Candrilli SD; Manjunath R; Davis KL; Gidal BE
Epilepsy Res; 2010 Oct; 91(2-3):260-6. PubMed ID: 20801617
[TBL] [Abstract][Full Text] [Related]
31. Statin medication in patients treated with antiepileptic drugs in Norway.
Gedde-Dahl A; Devold HM; Molden E
Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):881-5. PubMed ID: 22529023
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular risk stratification in overweight or obese patients in primary prevention. Implications for use of statins.
Masson W; Lobo M; Huerín M; Molinero G; Manente D; Pángaro M; Vitagliano L; Zylbersztejn H
Endocrinol Nutr; 2015 Feb; 62(2):83-90. PubMed ID: 25573227
[TBL] [Abstract][Full Text] [Related]
33. Comparing Guidelines for Statin Treatment in Canada and the United States.
Hennessy DA; Bushnik T; Manuel DG; Anderson TJ
J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175357
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular risk factors in chronic treatment with antipsychotic agents used in primary care.
Mundet-Tudurí X; Iglesias-Rodal M; Olmos-Domínguez C; Bernard-Antoranz ML; Fernández-San Martín MI; Amado-Guirado E
Rev Neurol; 2013 Dec; 57(11):495-503. PubMed ID: 24265143
[TBL] [Abstract][Full Text] [Related]
35. Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox.
Ko DT; Mamdani M; Alter DA
JAMA; 2004 Apr; 291(15):1864-70. PubMed ID: 15100205
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of cardiovascular risk factors in Indian patients undergoing coronary artery bypass surgery.
Kasliwal RR; Kulshreshtha A; Agrawal S; Bansal M; Trehan N
J Assoc Physicians India; 2006 May; 54():371-5. PubMed ID: 16909733
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study.
Glass TR; Ungsedhapand C; Wolbers M; Weber R; Vernazza PL; Rickenbach M; Furrer H; Bernasconi E; Cavassini M; Hirschel B; Battegay M; Bucher HC;
HIV Med; 2006 Sep; 7(6):404-10. PubMed ID: 16903986
[TBL] [Abstract][Full Text] [Related]
38. The gap between the current dyslipidemia guidelines and the physicians' treatment targets in patients with type 2 diabetes in Turkey.
Kahya Eren N; Harman E; Dolek D; Emren S; Tütüncüoğlu AP; Nazli C; Ergene O
Minerva Cardioangiol; 2014 Jun; 62(3):287-95. PubMed ID: 24831765
[TBL] [Abstract][Full Text] [Related]
39. Under-prescription of statins in patients with non-alcoholic fatty liver disease.
Del Ben M; Baratta F; Polimeni L; Pastori D; Loffredo L; Averna M; Violi F; Angelico F
Nutr Metab Cardiovasc Dis; 2017 Feb; 27(2):161-167. PubMed ID: 27914698
[TBL] [Abstract][Full Text] [Related]
40. [Cardiovascular risk factors in Algeria. Analysis of the subgroup from the "Africa/Middle East Cardiovascular Epidemiological" Study].
Brouri M; Ouadahi N; Nibouche D; Benabbas Y; El Hassar M; Bouraoui S; Abad N; Abreu PC; Ikardouchene L
Ann Cardiol Angeiol (Paris); 2018 Apr; 67(2):61-66. PubMed ID: 29530274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
